Advanced Search

 

Study ID Status Title Patient Level Data
FLTA4039 Completed A randomized, double-blind, parallel group comparison study of inhaled fluticasone propionate (88mcg BID) versus montelukast sodium (10mg QD) in subjects currently receiving beta agonists alone.
FLTB1001 Completed To compare the effects of the dosing schedule of inhaled Fluticasone propionate using various tests of HPA-axis function.
FLTB1003 Completed A study to assess the effects of ketoconazole on the pharmacokinetics and systemic pharmacodynamics of inhaled fluticasone propionate in healthy volunteers
FLTB1006 Completed Pharmacokinetic and pharmacodynamic evaluation of Fluticasone propionate and Budesonide after single and bi-daily inhaled administration over 5 days
FLTB1009 Completed A study to investigate the plasma concentrations of fluticasone propionate (FP) after intranasal administration of four 800 mg doses of FP given over two days as either preservative-free nasal drops or an aqueous nasal spray.
FLTB1016 Completed A randomised, double blind (with respect to placebo within a device), incomplete block design study to assess the systemic pharmacodynamics and pharmacokinetics of intranasal and intravenous fluticasone propionate administered via either: a nasal aerosol in propellant HFA134a (200µg, 2400µg), an ...
FLTB1020 Completed A Dose Proportionality Study of Fluticasone Propionate from 50, 125, and 250mcg HFA Inhalers and Comparability to 125 and 250mcg CFC Inhalers
FLTB3001 Completed A multicentre, randomised, double blind, parallel group study to compare the oral steroid-sparing effect of nebulised fluticasone propionate 2mg twice daily and 0.5mg twice daily with placebo in patients with chronic severe asthma.
FLTB3002 Completed A multicentre, randomised, double-blind, parallel group clinical trial to determine the safety and efficacy of nebulised fluticasone propionate 1mg twice daily compared with oral soluble prednisolone administered for 7 days to children aged 4 to 16 years with an acute asthma exacerbation.
FLTB3004 Completed A multicentre, randomised, double-blind, parallel-group study to compare the efficacy and tolerability of fluticasone proprionate 100mg bd administered by pressurised inhaler propelled by a mixture of propellants 11 and 12 or by an alternative propellant, GR106642X for a period…
FLTB3006 Completed A multicentre, randomised, double-blind, crossover study to compare the efficacy and tolerability of fluticasone propionate 2 mg daily administered by pressurised inhaler propelled by a mixture of propellants 11/12 or by an alternative propellant, GR106642X in adult patients with severe reversib ...
FLTB3009 Completed A multicentre, randomised, double-blind, double-dummy, parallel-group study to determine the clinical equivalence between fluticasone propionate 250mg twice daily delivered via a multidose powder inhaler (MDPI) and the Diskhaler in adult patients with reversible airways disease.
FLTB3012 Completed A multicentre, randomised, double-blind, parallel group study to compare the efficacy and tolerability of fluticasone propionate (250 mg bd) administered by pressurised inhaler propelled by a mixture of propellants 11 and 12 or by an alternative propellant, GR106642X in adult patients…
FLTB3013 Completed A multi-centre, randomised, double-blind, parallel-group clinical trial to compare the safety and efficacy of the dry powder formulation of fluticasone propionate 400mg/day and beclomethasone dipropionate 400mg/day administered for 12 weeks to paediatric patients with chronic asthma.
FLTB3014 Completed A multicenter, randomised, double-blind, double-dummy, parallel group clinical trial to determine the safety and efficacy of inhaled fluticasone propionate 500 mg bd metered dose inhaler with a Volumatic™ spacer compared to oral soluble prednisolone administered for 7 days to patients aged…
FLTB3015 Completed A multi-centre, randomized, double-blind, parallel-group clinical trial to compare the safety and efficacy of the dry powder formulation of fluticasone propionate 400mg/day and beclomethasone dipropionate 400mg/day administered for 52 weeks to paediatric patients with chronic asthma
FLTB3016 Completed A multi-centre, randomised, double-blind, placebo-controlled parallel group study to determine the efficacy and safety of inhaled fluticasone propionate 50mg bd and 100mg bd delivered via the Babyhaler™ spacer device in the management of asthma symptoms in children aged 12-47 months inclusive.
FLTB3017 Completed A multi-centre, randomised, double-blind, placebo-controlled parallel group study to determine the efficacy and safety of inhaled fluticasone propionate 100mg bd and 250mg bd delivered via the Babyhaler™ spacer device in the management of asthma symptoms in children aged 12–47 months inclusive.
FLTB3021 Completed A double-blind, double-dummy, randomised, parallel group study to evaluate the early substitution of nebulised fluticasone propionate (FP) 2mg twice daily (bd) for oral prednisolone 50mg once daily (od) during the early recovery period after an acute exacerbation of asthma in adult patients.
FLTB3026 Completed A single centre, randomised, double-blind, cross-over study to determine the effects of fluticasone propionate (Flixotidea) 500µg BD delivered via the MDI and spacer compared with placebo on the cellular and cytokine characteristics of induced sputum in subjects with COPD.
FLTB3030 Completed A phase III, multi-centre, double-blind, randomised, cross-over group study to evaluate the efficacy and safety of fluticasone propionate Nebules 0.5mg twice daily compared with placebo in the treatment of symptomatic asthma in children under 4 years of age.
FLTB3031 Completed A randomised, double-blind, parallel-group clinical trial to establish the safety and efficacy of nebulised fluticasone propionate 1mg twice daily compared with oral prednisolone administered for 7 days to pre-school children aged 48 months or less with an acute exacerbation of asthma.
FLTB3036 Completed A single-centre, randomised, double-blind, parallel group study to investigate the effects of high-dose inhaled corticosteroid therapy on bone mass in adult patients with moderately severe asthma
FLTB3038 Completed A study to investigate the effectiveness of fluticasone propionate (FP) 200 mg/day versus beclomethasone dipropionate (BDP) 400 mg/day delivered via the Babyhaler™ spacer device in patients with a history of wheeze aged 2 to 18 months.
FLTB3039 Completed A multi-centre, randomised, double-blind, parallel group study of the efficacy and safety of inhaled fluticasone propionate 1000mg daily with placebo in chronic obstructive pulmonary disease

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.